Plaque Psoriasis
📧 Sign up to get email alerts when something new happens for Plaque Psoriasis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-02-15FDA Approved: SILIQ — Original Application (Bausch Health US LLC)
FDA approved SILIQ (brodalumab) from Bausch Health US LLC in its Original Application for adults with moderate-to-severe plaque psoriasis, w…
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305) [Phase 3]
Phase 3 study comparing 000-0551 Lotion to vehicle in plaque psoriasis completed; results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail Psoriasis [Phase 3]
Phase 3 study evaluating the safety and efficacy of adalimumab in subjects with chronic plaque psoriasis and nail psoriasis. Results have be…
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Pediatric Open-Label Extension Study of Etanercept in Patients With Plaque Psoriasis [Phase 3]
Phase 3 pediatric open-label extension study of etanercept in pediatric plaque psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: Paired-Comparison Study Evaluating the Efficacy and Safety of E6201 Versus Vehicle for the Treatment of Plaque-Type Psoriasis [Phase 2]
A Phase 2 paired-comparison trial evaluated the efficacy and safety of E6201 versus vehicle in chronic plaque psoriasis. The study is comple…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: A Study of Topical Indigo Naturalis Treatment in Patients With Mild to Moderate Plaque-type Psoriasis [Phase 2]
This document reports the completion of a Phase 2 trial evaluating topical Indigo Naturalis for mild to moderate plaque-type psoriasis.
-
CLINICAL_TRIALS trial_result · 2017-01-16Clinical Trial Update: CLEAR Study: Clinical Experience Acquired With Raptiva Study [Phase 3]
An update on the Phase 3 CLEAR study reports clinical experience with efalizumab (Raptiva) in patients with moderate-to-severe psoriasis. Th…
-
FDA approval · 2017-01-11FDA Approved: OTREXUP — Supplemental Application (Antares Pharma, Inc.)
The FDA approved a supplemental application for OTREXUP (methotrexate) filed by Antares Pharma, Inc. This update expands the regulatory auth…
-
CLINICAL_TRIALS trial_result · 2016-12-29Clinical Trial Update: Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque Psoriasis [Phase 4]
A Phase 4 trial evaluated the immunogenicity and safety of etanercept produced with a modified manufacturing process in adults with plaque p…
-
CLINICAL_TRIALS trial_result · 2016-12-21Clinical Trial Update: Laser-assisted Topical Administration of Etanercept (Enbrel®) in Patients With Mild to Moderate Plaque-type Psoriasis [Phase 1]
Phase 1 trial update evaluating laser-assisted topical delivery of etanercept (Enbrel) for patients with mild to moderate plaque psoriasis.
-
FDA approval · 2016-12-13FDA Approved: DERMOTIC — Supplemental Application (Royal Pharmaceuticals)
The FDA approved a supplemental application for DERMOTIC (fluocinonide acetate) from Royal Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: Study to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Plaque Psoriasis [Phase 3]
Phase 3 trial comparing ABP 501 to Adalimumab in adults with moderate to severe plaque psoriasis has completed with results posted.
-
CLINICAL_TRIALS withdrawal · 2016-12-05Clinical Trial Update: A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild to Moderate Plaque Psoriasis [Phase 2]
A Phase 2 proof-of-concept study evaluating 0.5% roflumilast cream for mild-to-moderate plaque psoriasis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis [Phase 2]
Phase 2 trial comparing AM001 Cream to vehicle for plaque psoriasis has completed.
-
CLINICAL_TRIALS withdrawal · 2016-11-29Clinical Trial Update: Post Marketing Observational Study on Venezuelan Patients With Psoriasis
A post-marketing observational study in Venezuelan patients with chronic plaque psoriasis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-11-17Clinical Trial Update: Olux E Foam and Sorilux Foam Combination Therapy for the Maintenance of Treatment Response in Patients With Moderate Plaque Psoriasis [Phase 4]
Phase 4 trial evaluating maintenance of treatment response in moderate plaque psoriasis with combination therapy of Olux E Foam (clobetasol …
-
CLINICAL_TRIALS trial_result · 2016-11-07Clinical Trial Update: A Study of Ustekinumab to Evaluate a "Subject-tailored" Maintenance Dosing Approach in Subjects With Moderate-to-Severe Plaque Psoriasis [Phase 3]
Phase 3 clinical trial evaluating a subject-tailored maintenance dosing approach for ustekinumab in adults with moderate-to-severe plaque ps…
-
CLINICAL_TRIALS trial_result · 2016-11-03Clinical Trial Update: Generic Tazarotene Cream, 0.05% for the Treatment of Plaque Psoriasis [Phase 3]
Phase 3 clinical trial of generic tazarotene cream 0.05% for plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis. [Phase 2]
Phase 2 study of R3421 in patients with moderate-to-severe chronic plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-11Clinical Trial Update: Skin Transcriptional Profiles In Psoriatic Patients Under Adalimumab Biotherapy [Phase 2]
Phase 2 trial evaluating skin transcriptional profiles in patients with chronic plaque psoriasis treated with adalimumab; study status is co…
-
CLINICAL_TRIALS trial_result · 2016-10-05Clinical Trial Update: Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis [Phase 2]
Pfizer's Phase 2 study of PF-04965842 for plaque psoriasis was terminated. The results have been posted.
-
FDA approval · 2016-09-23FDA Approved: USTEKINUMAB — Original Application (Janssen Biotech, Inc.)
FDA approved ustekinumab (brand name Stelara) in its original application for the treatment of moderate to severe plaque psoriasis in adults…
-
CLINICAL_TRIALS withdrawal · 2016-08-09Clinical Trial Update: Efficacy Study on Dimethyl Fumarate to Treat Moderate to Severe Plaque Psoriasis [Phase 3]
Clinical trial update indicates that the Phase 3 efficacy study of Dimethyl Fumarate for moderate-to-severe plaque psoriasis has been withdr…
-
FDA approval · 2016-06-30FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved a supplemental application for Humira (adalimumab) to Cordavis Limited, authorizing the continued manufacturing/supply of the p…
-
CLINICAL_TRIALS trial_result · 2016-06-29Clinical Trial Update: Adalimumab-psoriasis and Small Bowel Lesions [Phase 4]
Phase 4 clinical trial update indicating the study of adalimumab for plaque psoriasis and Crohn's disease with completion of the trial.